Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Z Rheumatol ; 81(7): 610-618, 2022 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-35513537

RESUMEN

Lung involvement is the most frequent cause of death in patients with systemic sclerosis (SSc). As lung involvement is frequently asymptomatic, the current recommendation is to carry out thoracic computed tomography (CT) in all patients newly diagnosed with SSc. There is currently disagreement on how patients with SSc for whom no lung involvement was found at the time of diagnosis, should be followed up. Based on a consensus of Austrian rheumatologists, pneumologists and radiologists it is recommended that for asymptomatic patients with a negative CT at the time of initial diagnosis, a transthoracic ultrasound examination should be carried out annually and a lung function examination every 6-12 months. In the presence of a positive lung ultrasound finding a supplementary CT for further clarification is recommended. Based on the data situation, annual CT follow-up controls are recommended for patients with a high risk as defined by appropriate risk factors.


Asunto(s)
Esclerodermia Sistémica , Humanos , Pulmón/diagnóstico por imagen , Factores de Riesgo , Esclerodermia Sistémica/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Ultrasonografía
2.
Wien Klin Mag ; 23(3): 92-115, 2020.
Artículo en Alemán | MEDLINE | ID: mdl-32427192

RESUMEN

The COVID-19 pandemic is currently a challenge worldwide. In Austria, a crisis within the health care system has so far been avoided. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV­2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic. However, COVID-19-specific adjustments are useful. The treatment of patients with chronic lung diseases must be adapted during the pandemic, but must still be guaranteed.

3.
Eur Respir J ; 33(4): 931-4, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19336595

RESUMEN

The aim of the present study was to investigate a case of hypersensitivity pneumonitis associated with the use of temozolomide in the treatment of gliosarcoma. A 54-yr-old female developed dyspnoea, cough and hypoxia after surgical resection for gliosarcoma and adjuvant radio- and chemotherapy with temozolomide. A high-resolution computed tomography scan of the thorax showed a bilateral ground-glass pattern. Bronchoscopy with bronchoalveolar lavage and lung biopsies was performed. Bronchoalveolar lavage demonstrated significant lymphocytic alveolitis and transbronchial lung biopsies revealed lymphocytic infiltration with foamy macrophages, consistent with hypersensitivity pneumonitis. There was no evidence of other causes, including infections. After withdrawing temozolomide and initiating prednisolone therapy, the patient had no further pulmonary symptoms. To the present authors' knowledge, this is the first definitively described case of temozolomide-associated hypersensitivity pneumonitis.


Asunto(s)
Alveolitis Alérgica Extrínseca/inducido químicamente , Antineoplásicos Alquilantes/efectos adversos , Dacarbazina/análogos & derivados , Alveolitis Alérgica Extrínseca/diagnóstico por imagen , Alveolitis Alérgica Extrínseca/tratamiento farmacológico , Biopsia , Broncoscopía , Dacarbazina/efectos adversos , Femenino , Glucocorticoides/uso terapéutico , Humanos , Persona de Mediana Edad , Prednisolona/uso terapéutico , Temozolomida , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA